Protalix BioTherapeutics awarded insider Bar-Shalev Amos 25,500 derivative securities across two transactions on 2026-09-03 at $0 per share. The award matters to investors because the reported post-transaction holding was 8,500 derivative securities, giving shareholders a specific update on the insider’s stated ownership.

Key Highlights

  • Bar-Shalev Amos held 8,500 derivative securities after the transactions.
  • The award was completed across two separate transactions.
  • Each transaction carried a price of $0 per share.

Protalix BioTherapeutics, Inc. (AMEX: PLX) awarded Bar-Shalev Amos 25,500 derivative securities across two transactions, with each transaction priced at $0 per share. Amos is identified as an insider of Protalix BioTherapeutics. The two transactions were dated 3 September 2026.

Two-Transaction Award Totals 25,500 Securities

The 25,500 derivative securities represent the combined award across the two transactions. Both transactions were recorded at $0 per share. After the transactions, Amos owned 8,500 derivative securities.